Amylin Pharmaceuticals to Present at Annual Meeting of Stockholders
May 08 2012 - 4:15PM
Business Wire
Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will webcast its
Annual Meeting of Stockholders on Tuesday, May 15, 2012 at 9:00
a.m. PT/ 12:00 p.m. ET from the Company's corporate headquarters in
San Diego. Following the Annual Meeting, Daniel M. Bradbury,
president and chief executive officer of Amylin Pharmaceuticals,
will provide a corporate overview.
The call will be webcast live through the "Investors" section of
Amylin's corporate website and a recording will be made available
following the close of the call. To access the webcast, please log
on to www.amylin.com approximately 15 minutes prior to the call to
register, download and install any necessary audio software. For
those without access to the Internet, the live call may be accessed
by phone by calling (888) 989-4344 (U.S./Canada) or (312) 470-7140
(international), participant passcode number 7994841. A replay of
the call will also be available by phone beginning approximately
two hours after the close of the call and can be accessed at (800)
388-5290 (U.S./Canada) or (203) 369-3692 (international).
About Amylin PharmaceuticalsAmylin Pharmaceuticals is a
biopharmaceutical company dedicated to improving lives of patients
through the discovery, development and commercialization of
innovative medicines. Amylin is committed to delivering novel
therapies that transform the way diabetes and other metabolic
disorders are treated. Amylin is headquartered in San Diego,
Calif., and has a commercial manufacturing facility in Ohio. More
information on Amylin Pharmaceuticals is available at
www.amylin.com.
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jul 2023 to Jul 2024